SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-19-015494
Filing Date
2019-05-03
Accepted
2019-05-03 06:05:37
Documents
13
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 6-K tlc-6k_20181231.htm 6-K 20944
2 EX-99.1 tlc-ex991_6.htm EX-99.1 1973113
3 GRAPHIC guas3ifdacwn000011.jpg GRAPHIC 6491
4 GRAPHIC guas3ifdacwn000010.jpg GRAPHIC 6426
5 GRAPHIC guas3ifdacwn000001.jpg GRAPHIC 3806
6 GRAPHIC guas3ifdacwn000007.jpg GRAPHIC 6491
7 GRAPHIC guas3ifdacwn000008.jpg GRAPHIC 5664
8 GRAPHIC guas3ifdacwn000005.jpg GRAPHIC 6571
9 GRAPHIC guas3ifdacwn000006.jpg GRAPHIC 6426
10 GRAPHIC guas3ifdacwn000004.jpg GRAPHIC 34658
11 GRAPHIC guas3ifdacwn000002.jpg GRAPHIC 2602
12 GRAPHIC guas3ifdacwn000003.jpg GRAPHIC 2486
13 GRAPHIC guas3ifdacwn000009.jpg GRAPHIC 6571
  Complete submission text file 0001564590-19-015494.txt   2118329
Mailing Address 2F, 3 YUANQU STREET NANGANG DISTRICT TAIPEI CITY F5 11503
Business Address 2F, 3 YUANQU STREET NANGANG DISTRICT TAIPEI CITY F5 11503 886 2 2655 7377
Taiwan Liposome Company, Ltd. (Filer) CIK: 0001722890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: F5 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38746 | Film No.: 19793988
SIC: 2834 Pharmaceutical Preparations